Instrument Inactif
Dividendes sectoriels Endonovo Therapeutics Inc OTC Bulletin Board
Actions
US4111551044
Recherche biotechnologique et médicale
|
Cours en clôture
OTC Bulletin Board
|
||
| - USD | - |
|
Principaux concurrents
Ajouter à une liste 0 sélectionné | Rendement du dividende (Y) | Rendement du dividende (Y+1) | PER (Y) | Price to Book (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 1,44 % | 1,58 % | 20.63x | 4.87x | 7.28x | 14.62x | 16.26x | 70,24 Md | |
| 0,04 % | 0,08 % | 32.28x | 6.4x | 9.34x | 45.05x | 29.57x | 62,63 Md | |
| -.--% | -.--% | -76.7x | 38.38x | 14.8x | -71.37x | -85.9x | 27,36 Md | |
| -.--% | -.--% | 29.77x | 3.12x | 6.32x | 16.41x | 19.68x | 25,71 Md | |
| -.--% | -.--% | -15.03x | 1.23x | 5.62x | -7.06x | -5.57x | 24,83 Md | |
| -.--% | -.--% | 26.45x | 3.15x | 5.03x | 16.73x | 18.75x | 19,52 Md | |
| 0,34 % | 0,2 % | 44.88x | 11.17x | 16.47x | 33.42x | 36.09x | 15,51 Md | |
| -.--% | -.--% | 1267.62x | 16.98x | 36.68x | 797.93x | -237.35x | 14,66 Md | |
| -.--% | -.--% | -15.8x | 54.01x | 3569.89x | -18.25x | -15.68x | 14,69 Md | |
| -.--% | -.--% | 17.36x | 5.35x | 5.16x | 12.06x | 12.78x | 13,93 Md | |
| -.--% | -.--% | -85.53x | 27.79x | 7.83x | -64.86x | -63.49x | 12,48 Md | |
| -.--% | -.--% | -22.16x | 29.26x | 22.9x | -24.91x | -22.13x | 11,39 Md | |
| -.--% | 0,01 % | -414.37x | 8.42x | 15.29x | 950.13x | -320.68x | 11,24 Md | |
| -.--% | -.--% | -11.83x | -75.95x | 59.49x | -12.41x | -12.18x | 10,07 Md | |
| -.--% | -.--% | -7.11x | - | - | -7.36x | -6.81x | 8,86 Md | |
| -.--% | -.--% | 8.29x | 4.59x | 6.95x | 11.29x | 11.67x | 8,23 Md | |
| -.--% | -.--% | -31.03x | 8.16x | - | -27.3x | -28.18x | 8,01 Md | |
| Moyenne | 0,11 % | 0,11 % | 45,16x | 9,18x | 252,61x | 97,89x | -38,42x | 21,14 Md | |
| Moyenne pondérée par Capi. | 0,3 % | 0,33 % | 42,40x | 9,61x | 164,70x | 66,38x | -18,25x |
- Bourse
- Actions
- Action ENDV
- Action
- Secteur Endonovo Therapeutics Inc
- Dividendes sectoriels
🔇
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
